Does the Disinfection of the Subcutaneous Tissue Reduce the Contamination of the Operative Field by P. Acnes During Primary Shoulder Surgery?
1 other identifier
interventional
105
1 country
1
Brief Summary
Propionibacterium acnes is a pathogen frequently identified during postoperative infections of the shoulder. A recent study has shown that P. acnes is likely to be disseminated in the operative field from the subcutaneous layer by soft tissue manipulation by the surgeon and the instruments (Falconer 2016). This study seeks to evaluate the effectiveness of subcutaneous tissue disinfection on P. acnes contamination during primary shoulder surgery. The literature shows that approximately one-third of patients have a P. acnes-infected surgical drape during primary shoulder arthroplasty (Falconer 2016). The source of this contamination would be the subcutaneous tissue. The hypothesis is that a disinfection of the subcutaneous tissue would reduce the contamination of the operative field with the aim of reducing the infection rate after shoulder surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2018
CompletedFirst Posted
Study publicly available on registry
September 10, 2018
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedFebruary 13, 2020
February 1, 2020
2.7 years
September 7, 2018
February 11, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
positive bacteriological sample
To compare the positive bacteriological sample rate during open shoulder surgery with subcutaneous tissue disinfection compared to an identical procedure that does not include this step.
operation day
Study Arms (2)
intervention group
ACTIVE COMPARATORcontrol group
NO INTERVENTIONInterventions
The investigators will randomize 105 patient on two arms. The control group receiving no disinfection of the subcutaneous tissue (A) and intervention group, receiving disinfection of the subcutaneous tissue (B).
Eligibility Criteria
You may qualify if:
- = or\> 18 years
- Supported at the Valais Hospital for primary surgery of the shoulder.
- Have signed the consent
You may not qualify if:
- \<18 years old
- History of shoulder surgery
- History of infection of the shoulder
- Antibiotherapy in the 2 weeks preceding the intervention
- Infiltration of cortisone in the 6 months preceding the intervention
- Iodinated contrast medium allergy or cefuroxime
- Allergy to the povidone iodine complex or other contraindication to Betadine namely:
- Hypersensitivity to the active ingredient, iodine or povidone iodine complex, or to any of the excipients according to the composition.
- Hyperthyroidism and other overt thyroid diseases. Dermatitis herpetiformis of Duhring. Before and after radioactive iodine treatment (until the end of treatment)
- Refusal of the terms of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital du Valais
Martigny-Ville, Valais, 1920, Switzerland
Related Publications (1)
Falconer TM, Baba M, Kruse LM, Dorrestijn O, Donaldson MJ, Smith MM, Figtree MC, Hudson BJ, Cass B, Young AA. Contamination of the Surgical Field with Propionibacterium acnes in Primary Shoulder Arthroplasty. J Bone Joint Surg Am. 2016 Oct 19;98(20):1722-1728. doi: 10.2106/JBJS.15.01133.
PMID: 27869623BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Beat K Moor, PD Dr
Hopital du Valais
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PD Dr Moor, Head of departement of orthopedic surgery, Principal investigator
Study Record Dates
First Submitted
September 7, 2018
First Posted
September 10, 2018
Study Start
February 1, 2019
Primary Completion
October 1, 2021
Study Completion
October 1, 2022
Last Updated
February 13, 2020
Record last verified: 2020-02